Nkansah P, Antipas A, Lu Y, Varma M, Rotter C, Rago B, El-Kattan …shodhganga.inflibnet.ac.in/bitstream/10603/32498/16/16... · 2018. 7. 2. · References Dept of Pharmaceutics,

References

Dept of Pharmaceutics, JSSCP, Mysore 228

1. Nkansah P, Antipas A, Lu Y, Varma M, Rotter C, Rago B, El-Kattan A,

Taylor G, Rubio M, Litchfield J. Development and evaluation of novel solid

nanodispersion system for oral delivery of poorly water-soluble drugs. J

Control Release. 2013;169:150-61.

2. Elder DP, Holm R, Diego HLD. Use of pharmaceutical salts and cocrystals to

address the issue of poor solubility. Int J Pharm. 2013;453:88-100.

3. Shayanfar A, Zeynali KA, Jouyban A. Solubility and dissolution rate of a

carbamazepine-cinnamic acid cocrystal. J Mol Liquids. 2013;187:171-6.

4. Kawakami K. Modification of physicochemical characteristics of active

pharmaceutical ingredients and application of supersaturatable dosage forms

for improving bioavailability of poorly absorbed drugs. Adv Drug Deliv Rev.

2012;64:480-95.

5. Liversidge EM, Liversidge GG. Nanosizing for oral and parenteral drug

delivery: A perspective on formulating poorly-water soluble compounds using

wet media milling technology. Adv Drug Deliv Rev. 2011;63:427-40.

6. Baird JA, Taylor LS. Evaluation of amorphous solid dispersion properties

using thermal analysis techniques. Adv Drug Deliv Rev. 2012;64:396-421.

7. Aqil F, Munagala R, Jeyabalan J, Vadhanam MV. Bioavailability of

phytochemicals and its enhancement by drug delivery systems. Cancer Letters

2013;334:133-41.

8. Elder D, Holm R. Aqueous solubility: Simple predictive methods (in silico, in

vitro and bio-relevant approaches). Int J Pharm. 2013;453(1):3-11.

References


9. Delaney JS. Predicting aqueous solubility from structure. Drug Discov Today

Biosilico. 2005;10(4):289-95.

10. Holm R, Andresen L, Strange C. Oral bioavailability of a poorly aqueous drug

from three different SBE7-b-cyclodextrin based formulations in beagle dogs.

Results in Pharma Sci. 2011;1:57-9.

11. Stegemann S, Leveiller F, Franchi D, Jong HD, Linden H. When poor

solubility becomes an issue: From early stage to proof of concept. Eur J Pharm

Sci. 2007;31:249-61.

12. Mooter GVD. The use of amorphous solid dispersions: A formulation strategy

to overcome poor solubility and dissolution rate. Drug Discov Today Technol.

2012;9(2):e79-85.

13. Marc L, Sabine K, Dressman JB. Classification of orally administered drugs

on the World Health Organization Model list of Essential Medicines according

to the bio-pharmaceutics classification system. Eur J Pharm Biopharm.

2004;58:265-78.

14. Taupitz T, Dressman JB, Klein S. New formulation approaches to improve

solubility and drug release from fixed dose combinations: Case examples

pioglitazone/glimepiride and ezetimibe/simvastatin. Eur J Pharm Biopharm.

2013;84:208-18.

15. Serajuddin ATM. Salt formation to improve drug solubility. Adv Drug Deliv

Rev. 2007;59:603-616.

16. Miyako Y, Khalef N, Matsuzaki K, Pinal R. Solubility enhancement of

hydrophobic compounds by cosolvents: Role of solute hydrophobicity on the

solubilization effect. Int J Pharm. 2010;393:48-54.

References


17. Blagden N, De MM, Gavan PT, York P. Crystal engineering of active

pharmaceutical ingredients to improve. solubility and dissolution rates. Adv

Drug Deliv Rev. 2007;59:617-30.

18. Taupitz T, Dressman JB, Buchanan CM, Klein S. Cyclodextrin-water soluble

polymer ternary complexes enhance the solubility and dissolution behaviour

of poorly soluble drugs. Case example: Itraconazole. Eur J Pharm Biopharm.

2013;83:378-87.

19. Desai PP, Date AA, Patravale VB. Overcoming poor oral bioavailability using

nanoparticle formulations-opportunities and limitations. Drug Discov Today

Technol. 2012;9(2):e87-95.

20. Mishra B, Patel BB, Tiwari S. Colloidal nanocarriers: a review on formulation

technology, types and applications toward targeted drug delivery, Nanomed

Nanotechnol 2010;6:9-24.

21. Kalhapure RS, Akamanchi KG. Oleic acid based heterolipid synthesis,

characterization and application in self-microemulsifying drug delivery

system. Int J Pharm. 2012;425:9-18.

22. Patel PA, Chaulang GM, Akolkotkar A, Mutha SS, Hardikar SR, Bhosale AV.

Self Emulsifying Drug Delivery System: A Review. Research J Pharm Tech

2008;1(4):313-23.

23. Kumar A, Sharma S, Kamble R. Self emulsifying drug delivery system

(sedds): future aspects. Int J Pharmacy Pharm Sci. 2010;2(4):7-13.

24. Patel SN, Patel DM, Patel CN, Patel TD, Prajapati PH, Parikh BN. Self

emulsifying drug delivery system. J Global Pharma Tech. 2010;2(2):29-37.

References


25. Mehta RR, Borisagar KJ, Kapadiya KR. Self-micro emulsifying drug delivery

system: an approach to increase oral bioavailability. Ph Tech Med.

2012;6(1):197-202.

26. Gupta S, Chavhan S, Sawant KK. Self-nanoemulsifying drug delivery system

for adefovir dipivoxil: Design, characterization, in vitro and ex vivo

evaluation. Colloid Surfaces A. 2011;392:145-55.

27. Zhang J, Gao Y, Qian S, Liu X, Zu H. Physicochemical and pharmacokinetic

characterization of a spray-dried malotilate emulsion. Int J Pharm.

2011;414:186-92.

28. Hu X, Lin C, Chen D, Zhang J, Liu Z, Wu W, Song H. Sirolimus solid self-

microemulsifying pellets: Formulation development, characterization and

bioavailability evaluation. Int J Pharm. 2012;438:123-33.

29. Wang Z, Sun J, Wang Y, Liu X, Liu Y, Fu Q, Meng P, He Z. Solid self-

emulsifying nitrendipine pellets: Preparation and in vitro/in vivo evaluation.

Int J Pharm. 2010;383:1-6.

30. Horter D, Dressman JB. Influence of physicochemical properties on

dissolution of drugs in the gastrointestinal tract. Adv Drug Deliv Rev.

2001;46:75-87.

31. Kawabata Y, Wada K, Nakatani M, Yamada S, Onoue S. Formulation design

for poorly water-soluble drugs based on biopharmaceutics classification

system: Basic approaches and practical applications. Int J Pharm. 2011;420:1-

10.

32. http://www.drugbank.ca/drugs/DB00625

33. http://www.rxlist.com/sustiva-drug.htm

References


34. http://www.drugbank.ca/drugs/APRD00055

35. http://www.rxlist.com/lipitor-drug.htm

36. http://www.rxlist.com/crestor-drug.htm

37. http://www.drugbank.ca/drugs/DB01098

38. Brown CK, Chokshi HP, Nickerson B, Reed RA, Rohrs BR, Shah PA.

Acceptable analytical practices for dissolution testing of poorly soluble

compounds. Pharma Techn. 2004:56-65.

39. Sachan NK, Biopharmaceutical classification system: A strategic tool for oral

drug delivery technology. Asian J Pharma. 2009;3(2):76-81.

40. Sachan R, Khatri K, Kasture SB. Self-Emulsifying Drug Delivery System: A

novel approach for enhancement of bioavalibility. Int J Pharm Tech Res.

2010;2(3):1738-45.

41. Arida AI, Al-Tabakha MM, Hamoury HAJ. Improving the high variable

bioavailability of griseofulvin by SEDDS. Chem Pharm Bull.

2007;55(12):1713-9.

42. Khoo SM, Humberstone AJ, Porter CJ, Edwards GA and Charman WN.

Formulation design and bioavailability assessment of lipidic self-emulsifying

formulations of halofantrine. Int J Pharm. 1998;167:155-64.

43. Yetukuri K, Sudheer P. Approaches to development of solid self

microemulsifying drug delivery system: formulation techniques and dosage

forms: a review. IJPSR. 2012;3:3550-8.

References


44. Sarpal K, Pawar BY, Bansal AK. Self-emulsifying drug delivery systems: A

strategy to improve oral bioavailability. Curr Res & Inf Pharma Sci.

2010;11(3):42-9.

45. Nidhi M, Shikha S. New Strategy for Solubilization of poorly soluble drug-

SEDDS. Der Pharmacia Lettre. 2009;1(2):60-67.

46. Kawakami K, Yoshikawa T, Moroto Y, Kanakao E, Takahuani K, Nishihara

Y, Masuda K. Nanoemulsion formulation for enhanced absorption of poorly

soluble Drugs. I. Prescription design. J Control Release. 2002;81:75-82.

47. Prajapati BG, Patel MM. Conventional and alternative pharmaceutical

methods to improve oral bioavailability of lipophilic drugs. Asian J Pharma.

2007;1(1):1-8.

48. Makadia HA, Bhatt AY., Parmar R B., Paun J S, Tank H.M. Self-nano

Emulsifying Drug Delivery System (SNEDDS): Future Aspects. Asian J

Pharm Res. 2013;3(1):21-7.

49. Sharma S, Bajaj H, Bhardwaj P, Sharma AD and Singh R. Development and

characterization of self emulsifying drug delivery system of a poorly water

soluble drug using natural oil. Acta Pol Pharma. 2012;69(4)713-7.

50. Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for

improved oral delivery of lipophilic drugs. Biomed Pharmacother.

2004;58:173-82.

51. Tang J, Sun J, He ZG. Self-emulsifying drug delivery systems: strategy for

improving oral delivery of poorly soluble drugs. Current Drug Therapy.

2007;2:85-93.

References


52. Devani M, Ashford M, Craig DQ. The emulsification and solubilization

properties of polyglycolysed oils in self-emulsifying formulations. J Pharm

Pharmacol. 2004;56:307-16.

53. Anton N, Vandamme TF. The universality of low-energy nanoemulsification.

Int J Pharm. 2009;377:142-7.

54. Sadurni N, Solans C, Azemar N, Garcia-Celma MJ. Studies on the formation

of O/W nano-emulsions, by low-energy emulsification methods, suitable for

pharmaceutical applications. Eur J Pharm Sci. 2005;26:438-45.

55. Kamble VA, Jagdale DM, Kadam VJ. Self micro emulsifying drug delivery

system. Int J Pharm and Bio Sci. 2010;1(2):1-9.

56. Saxena S, Singh HN, Agrawal VK, Chaturvedi S. Lipid excipients in self

emulsifying drug delivery systems. Asian J Biomedical Pharma Sci.

2013;3(22):16-22.

57. Ozawa K, Olsson U, Cawes, A. Oil-induced structural change in nonionic

nanoemulsions. J Disp Sci and Tech. 1986;22(1):119-24.

58. El-Nokaly I, Ravey J. Solubilization by nonionic surfactant in the HLB

temperature range. in: micellization, solubilization and nanoemulsions,

(R.K.Mittal, ed.), Plennum press, New York. 1991;2:901-11.

59. Dey P, Maiti S, Ray S, Sa B, Sen K. Self-Emulsification of poorly soluble and

highly permeable drugs: an overview. Int J Pharma Recent Res. 2009;1(1):67-

72.

60. Gandhi A, Maji P. Self-emulsifying drug delivery system: an approach for

enhancement of bioavailability of poorly water soluble drugs. Int J Pharmacy

Integrated Life Sci. 2013;1(6):1-16.

References


61. Roop N G, Rakesh G, Singh RG. Enhancement of oral bioavailability of

lipophillic drugs from self-microemulsifying drug delivery system (smedds).

Int J Drug Dev & Res. 2009;1(1):10-18.

62. Porter CJ and Charman WN. In vitro assessment of oral lipid based

formulations. Adv Drug Deliv Rev. 2001;50:S127-47.

63. Jill SB, Akshay KR, Ketan RM, Rajesh PK. Self micro emulsifying drug

delivery system. Pharma Science Monitor. An Int J Pharma Sci. 2010;1(2):15-

33.

64. Caliph S, Charman WN, Porter CJ. Effect of short, medium and long chain

fatty acid based vehicles on the absolute oral bioavailability and intestinal

lymphatic transport of halofantrine and assessment of mass balance in lymph-

cannulated and noncannulated rats. J Pharm Sci. 2000;89:1073-84.

65. Nastasa V, Samaras K, Andrei IR, Pascu ML, Karapantsios T. Study of the

formation of micro and nano-droplets containing immiscible solutions.

Colloids and Surfaces A. 2011;382(1-3):246-50.

66. Patel MJ, Patel SS, Patel NM, Patel MM. A self-microemulsifying drug

delivery system (SMEDDS). Int J Pharma Sci Rev Res. 2010;4(3):29-35.

67. Kyatanwar AU, Gajbhiye ND, Jadhav KR, Kadam VJ. Solid self-emulsifying

drug delivery systems: A review. J Pharmacy Res. 2010;3(4):877-82.

68. Jannin V, Musakhanian J, Marchaud D. Approaches for the development of

solid and semi-solid lipid-based formulations. Adv Drug Deliv Rev.

2008;60:734-46.

References


69. Venkatesan N, Yoshimitsu J, Ito Y, Shibata N, Takada K. Liquid filled

nanoparticles as a drug delivery tool for protein therapeutics. Biomaterials.

2005;26:7154-7163.

70. Seo A. Holm P, Kristensen HG, Schaefer T. The preparation of agglomerates

containing solid dispersions of diazepam by melt agglomeration in a high

shear mixer, Int J Pharm. 2003;259:161-71.

71. Vipul PP, Tushar DR, Pankaj KP, Samir AA, Rajesh KA. Self emulsifying

drug delivery system: a conventional and alternative appproach to improve

oral bioavailability of lipophilic drugs. Int J Drug Dev & Res. 2010;2(4):859-

70.

72. Selvam PR, Kulkarni PK, Dixit M. solidification techniques and dosage form

development of solid self-emulsifying drug delivery systems: a technical note.

Elixir Pharmacy 2011;39:4753-4758.

73. Patel RP, Patel MP, Suthar AM. Spray drying technology: an overview. Indian

J Sci Technol. 2009;2(10):44-7.

74. Patel R, Kamble M, Katedeshmukh R, Zarikar N, Kulkarni A. A review on

solid self emulsifying drug delivery system. J Biomedical and Pharma Res.

2013;2(4):52-56.

75. Pradeep DH, Ram SS, Ketan KD, Ganesh OB, Deepika BR. A review on melt

granulation technique. J Pharm Phytother. 2013;1(3):6-10.

76. Rodriguez L, Passerini N, Cavallari C, Cini M, Sancin P, Fini A. Description

and preliminary evaluation of a new ultrasonic atomizer for spray-congealing

process, Int J Pharm. 1999;183:133-43.

References


77. Passerini N, Albertini B, Perissuti B, Rodriguez L. Evaluation of melt

granulation and ultrasonic spray congealing as techniques to enhance the

dissolution of praziquantel, Int J Pharm. 2006;318:92-102.

78. Dos Santos IR, Thies C, Richard J, Meurlay DL, Gajan V, Vandevelde V,

Benoit JP. A supercritical fluid bases coating technology. 2: solubility

considerations. J Microencapsu. 2003;20:97-109.

79. Kaur L, Kanojia N, Bala R, Nagpal M. Recent updates on self micro

emulsifying drug delivery systems. Am J Pharm Tech Res. 2013;3(1):261-88.

80. Mistry RB, Sheth NS. A review: self emulsifying drug delivery system. Int J

Pharm Pharm Sci. 2011;3(2):23-8.

81. Kyatanwas AU, Gajdhiye ND, Jadhav KR, Kadam VJ. Solid self emulsifying

drug delivery system: a review. J Pharmacy Res. 2010;3(4):877-82.

82. Nazzal S, Khan MA. Controlled release of a self emulsifying formulation from

a tablet dosage form: Stability Assessment & optimization of some processing

parameters. Int J Pharm. 2006;315:110-21.

83. Mahmoud EA, Bendas ER, Magdy IM. Preparation and evaluation of self

emulsifying tablets of carvedilol. AAPS Pharm Sci. 2009;10(1):183-92.

84. Serratoni, M, Newton M, Booth S, Clarke A. Controlled drug release from

pellets containing water insoluble drugs dissolved in a self-emulsifying

system. Eur J Pharm Biopharm. 2007;65:94-8.

85. Bajaj H, Bisht S, Yadav M, Singh V, Singh M. Self emulsifying drug delivery

system: an approach to enhance bioavailability. Int J Pharma Res and Dev.

2011;3(1):59-75.

References


86. Patil P, Joshi P, Paradkar A. effect of formulation variables on preparation and

evaluation of gelled selfemulsifying drug delivery system (SEDDS) of

Ketoprofen. AAPS PharmSci Tech. 2004;5:1-8.

87. Patil P, Biradar S, Paradkar A. extended release felodipine self-

nanoemulsifying system. AAPS PharmSciTech. 2009;10:515-23.

88. Tang B, Cheng G, Gu JC, Xu CH. Development of solid self-emulsifying drug

delivery systems: preparation techniques and dosage forms. Drug Discov

Today. 2008; 13(13/14):606-12.

89. Chaus HA, Chopade VV, Chaudhri PD. Self emulsifying drug delivery

system: a review. Int J Pharma Chem Sci. 2013;2(1):34-44.

90. Xiao L, Yi T. Mechanisms of hydroxypropyl methylcellulose for the

precipitation inhibitor of supersaturatable self-emulsifying drug delivery

systems. Acta Pharm Sin. 2013;48(5):767-72.

91. Agrawal S, Giri TK, Tripathi DK, Ajazuddin, Alexander A. A review on novel

therapeutic strategies for the enhancement of solubility for hydrophobic drugs

through lipid and surfactant based self micro emulsifying drug delivery

system: a novel approach. Amer J Drug Disc and Dev. 2012;2:143-83.

92. Chakraborty S, Shukla D, Mishra B, Singh S. Lipid-An emerging platform for

oral delivery of drugs with poor bioavailability. Eur J Pharma Biopharma.

2009;73:1-15.

93. Indian Pharmacopoeia. Controller of publication, New Delhi 2007;Vol

2,3:453-55,131-33,241,1062-63.

References


94. Rowe RC, Sheskey PJ, Quinn ME. Handbook of Pharmaceutical Excipients.

Sixth Edition. Pharmaceutical Press, London. 2009; 185-88, 517-22, 549-553,

592-94.

95. Schwendi MVS, Gruber M, Touraud D, Kunz W, Schmid C, Hirt SW, Lehle

K. Pharmacokinetics of a self-microemulsifying drug delivery system of

tacrolimus. Biomed Pharmacother. 2013;67:469-73.

96. Tran PHL, Tran TTD, Piao ZZ, Vo TV, Park JB, Lim J, Oh KT, Rhee YS, Lee

BJ. Physical properties and in vivo bioavailability in human volunteers of

isradipine using controlled release matrix tablet containing self-emulsifying

solid dispersion. Int J Pharm. 2013;450:79-86.

97. Saifee M, Zarekar S, Rao VU, Zaheer Z, Soni R, Burande S. Formulation and

In vitro evaluation of solid-self- emulsifying drug delivery system (SEDDS) of

glibenclamide. Amer J AdvDrug Deli. 2013;1(3):323-40.

98. Mekjaruskul C, Yang YT, Leed MGD, Sadgrove MP, Jay M, Sripanidkulchai

B. Novel formulation strategies for enhancing oral delivery of

methoxyflavones in Kaempferia parviflora by SMEDDS or complexation with

2-hydroxypropyl-β-cyclodextrin. Int J Pharm. 2013;445:1-11.

99. Dixit RP, Nagarsenker MS. Self-nanoemulsifying granules of ezetimibe:

Design, optimization and evaluation. Eur J Pharma Sci. 2008;35:183-92

100. Setthacheewakul S, Mahattanadul S, Phadoongsombut N, Pichayakorn W,

Wiwattanapatapee R. Development and evaluation of self-microemulsifying

liquid and pellet formulations of curcumin, and absorption studies in rats. Eur

J Pharm Biopharm. 2010;76(3):475-85.

References


101. Kallakunta VR, Bandari S, Jukanti R, Veerareddy PR. Oral self emulsifying

powder of lercanidipine hydrochloride: Formulation and evaluation. Powder

Technol. 2012;221:375-82.

102. Beg S, Jena SS, Patra CN, Rizwan M, Swain S, Sruti J, Rao MEB, Singh B.

Development of solid self-nanoemulsifying granules (SSNEGs) of

ondansetron hydrochloride with enhanced bioavailability potential. Colloids

and Surfaces B: Biointerfaces. 2013;101:414-23.

103. Agarwal V, Siddiqui A, Ali H, Nazzal S. Dissolution and powder flow

characterization of solid self-emulsified drug delivery system (SEDDS). Int J

Pharm. 2009;366:44-52.

104. Villar AMS, Naveros BC, Campmany ACC, Trenchs MA, Rocabert CB,

Bellowa LH. Design and optimization of self-nanoemulsifying drug delivery

systems (SNEDDS) for enhanced dissolution of gemfibrozil. Int J Pharm.

2012;431:161-75

105. Bhagwat DA, D’Souza JI. Formulation and evaluation of solid self micro

emulsifying drug delivery system using aerosil 200 as solid carrier. Int Curr

Pharma J. 2012;1(12):414-9

106. Shanmugam S, Baskaran R, Balakrishnan P, Thapa P, Yong CS, Yoo BK.

Solid self-nanoemulsifying drug delivery system (S-SNEDDS) containing

phosphatidylcholine for enhanced bioavailability of highly lipophilic bioactive

carotenoid lutein. Eur J Pharma Biopharm. 2011;79:250-7

107. Deshmukh A, Nakhat P, Yeole P. Formulation and in-vitro evaluation of self

microemulsifying drug delivery system (SMEDDS) of Furosemide. Der

Pharmacia Lettre. 2010;2(2):94-106.

References


108. Mandal S, Mandal SS, Sawant KK. Design and development of

microemulsion drug delivery system of atorvastatin and study its intestinal

permeability in rats. Int J Drug Deliv. 2010;2:69-75.

109. Viana ODS, Medeiros FPM, Júnior SG, Albuquerque MM. Development and

validation of a HPLC analytical assay method for efavirenz tablets: a medicine

for HIV infections. Braz J Pharm Sci. 2011;47(1):97-102

110. Chiappetta DA, Hocht C, Taira C, Sosnik A. Oral pharmacokinetics of the

anti-HIV efavirenz encapsulated within polymeric micelles. Biomaterials.

2011;32:2379-87

111. Mustafa G, Khan ZI, Bansal T, Talegaonkar S. preparation and

characterization of oil in water nano-reservoir systems for improved oral

delivery of atorvastatin. Current Nanoscience. 2009;5:428-40.

112. Novakova L, Satınsky D, Solich P. HPLC methods for the determination of

simvastatin and atorvastatin. Trend Anal Chem. 2008;27(4):352-67.

113. Shah DA, Bhatt KK, Mehta RS, Baldania SL, Gandhi TR. Stability indicating

RP-HPLC estimation of atorvastatin calcium and amlodipine besylate in

pharmaceutical formulations. Indian J Pharm Sci. 2008;70:754-60

114. Shah Y, Iqbal Z, Ahmad L, Khan A, Khan MI, Nazir S, Nasir F. Simultaneous

determination of rosuvastatin and atorvastatin in human serum using RP-

HPLC/UV detection: Method development, validation and optimization of

various experimental parameters. J Chromatography B. 2011;879:557-63

115. Bari HC, Doijad RC, More HN, Disouza JI. Design and optimization of

chlordiazepoxide solid self-microemulsifying drug delivery system. J Pharma

Res. 2011;4(2):369-72.

References


116. Surjyanarayan M, Snigdha MS, Naazneen S, Vandana BP. Design and

development of saquinavir microemulsion for the oral bioavailability

enhancement Int J PharmTech Res. 2009;1(4):1442-8.

117. Shafiq-un-Nabi S, Shakeel F, Talegaonkar S, Ali J, Baboota S, Ahuja A, Khar

RK, Mushir A. Formulation development and optimization using

nanoemulsion technique: A technical note. AAPS PharmSciTech.

2007;8(2):E1-E6.

118. Sheikh S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M.

Development and bioavailability assessment of ramipril nanoemulsion

formulation. Eur J Pharm Biopharm. 2007;66:227-43.

119. Date AA, Nagarsenker MS. Design and evaluation of self-nanoemulsifying

drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int J Pharma

2007;329:166-72.

120. Atef E, Belmonte AA. Formulation and in vitro and in vivo characterization of

a phenytoin self-emulsifying drug delivery system (SEDDS). Eur J Pharm Sci.

2008;35:257-63.

121. Harshal DM, Tanvir S, Dheeraj B, Rajendra DW. Design and development of

solid self-micro-emulsifying drug delivery system (SMEDDS) of fenofibrate.

Int J Pharm Pharm Sci. 2011;3(4):163-6

122. Kumar BP, Yunoos M, Chandana N, Habeeb M, Himaja B. Enhancement of

dissolution rate of efavirenz by solid dispersion technique. J Pharmacy Res.

2010;3(12):2840-2.

123. Gubbi SG, Jarag R. Formulation and characterization of atorvastatin calcium

liquisolid compacts. Asian J Pharma Sci. 2010;5(2):50-60.

References


124. Dwivedi J, Mahatma OP. Formulation & evaluation of sustained release

formulation of rosuvastatin calcium. Asian J Biochemical and Pharma Res.

2011;1(3):539-48.

125. Khule NR, Mahale NB, Chaudhari SR. Formulation development and

evaluation of once a day regioselective dual component gastroretentive tablet

of rosuvastatin calcium and metoprolol succinate. Int J Pharma Res & Dev.

2012;4(07):69-78.

126. Kang JH, Oh DH, Oh YK, Yong CS, Choi HG. Effects of solid carriers on the

crystalline properties, dissolution and bioavailability of flurbiprofen in solid

self-nanoemulsifying drug delivery system (solid SNEDDS). Eur J Pharma

Biopharm. 2012;80:289-97.

127. Zhou, Weilie, Wang, Zhong L. Scanning Microscopy for Nanotechnology :

Techniques and Applications,. New York:Springer 2007;1:522

128. Brittain H, Physical characterization of Pharmaceutical Solids, New York: M.

Dekker. 1995; 188-95.

129. Malakara J, Nayak AK. Formulation and statistical optimization of multiple-

unit ibuprofen-loaded buoyant system using 23-factorial design. Chem Eng

Res Des. 2012;90(11):1834-46.

130. Singh G, Pai RS, Devi VK. Response surface methodology and process

optimization of sustained release pellets using taguchi orthogonal array design

and central composite design. J Adv Pharm Tech Res. 2012;3(1):30-40.

131. Chivate N, Patil S, Saboji J, Chivate A. Formulation and optimization of

telmisartan solid dispersions by box-behnken design. Int J Pharm Sci Health

Care. 2012;3(2):33-47.

References


132. Sou T, Orlando L, McIntosh MP, Kaminskas LM, Morton DAV. Investigating

the interactions of amino acid components on a mannitol-based spray-dried

powder formulation for pulmonary delivery: A design of experiment approach.

Int J Pharm. 2011;421:220-9.

133. Swamy PV, Shahidulla SM, Shirsand SB, Hiremath SN, Ali MD.

Orodispersible tablets of carbamazepine prepared by direct compression

method using 32 full factorial design. Dhaka Univ J Pharm Sci. 2008;7(1):1-5.

134. Late SG, Yu YY, Banga AK. Effects of disintegration-promoting agent,

lubricants and moisture treatment on optimized fast disintegrating tablets. Int J

Pharm. 2009;365:4-11.

135. Kingori LD, Walker RB. The use of response surface methodology to evaluate

the impact of level 2 SUPAC-IR changes on the in vitro release of

metronidazole and ranitidine from a fixed-dose combination tablet. Dissolut

Technol. 2012:19(2):28-36.

136. Bayrak Z, Tas C, Tasdemir U, Erol H, Ozkan CK, Savaser A, Ozkan Y.

Formulation of zolmitriptan sublingual tablets prepared by direct compression

with different polymers: In vitro and in vivo evaluation. Eur J Pharm

Biopharm. 2011;78:499-505.

137. Venkata SM, Rao NS, Sunil SA, Ram BJ, Kolapalli VRM. Statistical design

and evaluation of a propranolol HCl gastric floating tablet. Acta

Pharmaceutica Sinica B. 2012;2(1):60-69

138. Chowdary KPR, Devi AGS. Preclinical pharmacokinetic evaluation of

Efavirenz-cyclodextrin - pvp inclusion complexes. Int J Pharm Sci Rev Res.

2012;15(1):23-6

References


139. ICH harmonized tripartite guidelines, Stability testing of new drug substances

and products. Q1A (R2). Federal Register, 2003;68,(225):65717-18.

140. Subramanian N, Ray S, Ghosal SK, Bhadra R, Moulik SP. Formulation design

of self-microemulsifying drug delivery systems for improved oral

bioavailability of celecoxib. Biol Pharm Bull. 2004;27:1993-9.

141. Taha EI. Development and characterization of new indomethacin self-

nanoemulsifying formulations. Saudi Pharma J. 2009;17(2):154-60.

142. Mudit D, Parthasarathi KP, Sojan J, Ashwini KG, Akash J. Formulation and

evaluation of positively charged self emulsifying drug delivery system

containing a NSAID. Int J Ph Sci. 2010;2(3):792-803.

143. Singh AK, Chaurasiya A, Singh M, Upadhyay SC, Mukherjee R, Khar RK.

Exemestane loaded self-microemulsifying drug delivery system (SMEDDS):

development and optimization. AAPS PharmSciTech. 2008;9(2):628-34

144. Chambin O, Jannin V, Champion D, Chevalier C, Gonthier MHG, Pourcelot

Y. Influence of cryogenic grinding on properties of a self-emulsifying

formulation. Int J Pharm. 2004;278:79-89.

145. Niederquell A, Volker AC, Kuentz M. Introduction of diffusing wave

spectroscopy to study self-emulsifying drug delivery systems with respect to

liquid filling of capsules. Int J Pharm. 2012;426:144-52.

146. Yogeshwar G. Bachhav and Vandana B. Patravale. SMEDDS of Glyburide:

formulation, in vitro evaluation, and stability studies. AAPS PharmSciTech.

2009;10(2):482-7.

References


147. Kokare CR, Kumbhar SA, Patil A. Formulation and evaluation of self-

emulsifying drug delivery system of carbamazepine. Ind J Pharm Edu Res.

2013;47(2):172-7.

148. Kassem AA, Marzouk MA, Ammar AA, Elosaily GH. Preparation and in vitro

evaluation of self-nanoemulsifying drug delivery systems (SNEDDS)

containing clotrimazole. Drug Discov Thera. 2010;4(5):373-9.

149. Franceschinis E, Bortoletto C, Perissutti B, Dal Zotto M, Voinovich D,

Realdon N. Self-emulsifying pellets in a lab-scale high shear mixer:

Formulation and production design. Powder Technol. 2011;207:113-8.

150. Iosio T, Voinovicha D, Perissutti B, Serdoza F, Hasaa D, Grabnarb I, Acqua

SD, Zarad GP, Muntonid E, Pinto JF. Oral bioavailability of silymarin

phytocomplex formulated as self-emulsifying pellets. Phytomedicine

2011;18:505-12.

151. Bhikshapathi D, Madhukar P, Kumar BP, Kumar GA. Formulation and

characterization of pioglitazone HCl self emulsifying drug delivery system.

Der Pharmacia Lettre. 2013;5(2):292-305.

152. Balakrishnan P, Lee BJ, Oh DH, Kim JO, Lee YI, Kim DD, Jee JP, Lee YB,

Woo JS, Yong CS, Choi HG. Enhanced oral bioavailability of Coenzyme Q10

by self-emulsifying drug delivery systems. Int J Pharm. 2009;374:66-72.

153. Porwal P, Bhargava S, Bhaduria RS, Shukla SS, Daharwal SJ. Formulation

and in-vitro characterization of self emulsifying drug delivery system of

cisapride. Adv Res Pharma Bio. 2012;2(IV):324-8.

154. Deshmukh A, Kulkarni S. Novel self micro-emulsifying drug delivery systems

(SMEDDS) of efavirenz. J Chem Pharma Res. 2012;4(8):3914-9.

References


155. Obitte NC, Chukwu A, Onyishi VI, Obitte BCN. The physicochemical

evaluation and applicability of Landolphia owariensis latex as a release

modulating agent in its admixture with carbosil in ibuprofen loaded self-

emulsifying oil formulations. Int J Applied Resin Natural Products.

2010;2(4):27-43.

156. Elnaggar YSR, El-Massik MA, Abdallah OY. Self-nanoemulsifying drug

delivery systems of tamoxifen citrate: Design and optimization. Int J Pharm.

2009;380:133-41.

157. Suresh PK, Sharma S. Formulation and in-vitro characterization of self-

nanoemulsifying drug delivery system of cinnarizine. Pharmacie Globale.

2011;9(08):1-6.

158. Choi YK, Poudel BK, Marasini N, Yang KY, Kim JW, Kim JO, Choi HG,

Yong CS. Enhanced solubility and oral bioavailability of itraconazole by

combining membrane emulsification and spray drying technique. Int J Pharm.

2012;434:264-71.

159. Meena AK, Sharma K, Kandaswamy M, Rajagopal S, Mullangi R.

Formulation development of an albendazole self-emulsifying drug delivery

system (SEDDS) with enhanced systemic exposure. Acta Pharm.

2012;62:563-80.

160. Milovic M, Djuris J, Djekic L, Vasiljevic D, Ibri S. Characterization and

evaluation of solid self-microemulsifying drug delivery systems with porous

carriers as systems for improved carbamazepine release. Int J Pharm.

2012;436:58-65.

References


161. Onoue S, Uchida A, Kuriyama K, Nakamura T, Seto Y, Kato M, Hatanaka J,

Tanaka T, Miyoshi H, Yamada S. Novel solid self-emulsifying drug delivery

system of coenzyme Q10 with improved photochemical and pharmacokinetic

behaviors. Eurp J Pharm Sci. 2012;46:492-9.

162. Patel AR, Vavia PR. Preparation and In Vivo Evaluation of SMEDDS (Self-

microemulsifying drug delivery system) Containing fenofibrate. The AAPS

Journal. 2007;9(3):E344-52.

163. Balakrishnan P, Lee BJ, Oh DH, Kim JO, Hong MJ, Jee JP, Kim JA, Yoo BK,

Woo JS, Yong CS, Choi HG. Enhanced oral bioavailability of dexibuprofen

by a novel solid self-nanoemulsifying drug delivery system (SEDDS). Eur J

Pharm Biopharm. 2009;72:539-45.

164. Sher P, Ingavle G, Ponrathnam S, Pawar AP. Low density porous carrier based

conceptual drug delivery system. Mesoporous Materials. 2007;102:290-98

165. Singh A, Pathak D, Pathak K. Use of Microporous Accurel MP1000 for

Duodenal Delivery of Secnidazole: A High Dose, Gastric pH Unstable Drug.

Int J Drug Delivery Tech. 2010;2(2):26-34.

166. Sinka IC, Motazedian F, Cocks ACF, Pitt KG. The effect of processing

parameters on pharmaceutical tablet properties. Powder Technol.

2009;189:276-84.

167. Pasqualoto KFM, Teofilo RF, Guterres M, Pereira FS, Ferreira MMC. A

study of physicochemical and biopharmaceutical properties of Amoxicillin

tablets using full factorial design and PCA biplot. Analytica Chimica Acta.

2007;595:216-20.

References


168. Gryczke A, Schminke S, Maniruzzaman M, Beck J, Douroumis D.

Development and evaluation of orally disintegrating tablets (ODTs) containing

Ibuprofen granules prepared by hot melt extrusion Colloids and Surfaces B:

Biointerfaces. 2011;86:275-84.

169. Dukic OA, Thommes M, Remon JP, Kleinebudde P, Vervaet C. Production of

pellets via extrusion-spheronisation without the incorporation of

microcrystalline cellulose: A critical review. Eur J Pharm Biopharm.

2009;71:38-46.

170. Naelapaa K, Veski P, Kristensen HG, Rantanen J, Bertelsen P.. Building

quality into a coating process. Pharm Dev Technol. 2010;15:35-45.

171. Gutierrez-Oppe EE, Salvagnini WM, Taqueda MES. Comparison between the

design of experiments and simulation in the three-phase distillation in a sieve

tray column for glycerine dehydration. Chem Eng Res Des. 2013;91:1186-

202.

172. Lafuente CS, Furlanetto S, Arevalo MF, Fuentes JA, Rabasco AM, Faucci

MT, Pinzauti S, Mura P. Didanosine extended-release matrix tablets:

optimization of formulation variables using statistical experimental design. Int

J Pharm. 2002;237:107-18

173. Bolhuis GK, Alderborn G, Nystrom C (Eds.). Materials for direct compaction

(Pharmaceutical Powder Compaction Technology). New York:Marcel Dekker;

1996.p. 419-478.

174. Shangraw RF, Lieberman HA, Lachman L, Schwartz JB. (Eds.), Compressed

tablets by direct compression (Pharmaceutical Dosage Forms: Tablets). 2nd

ed. New York:Marcel Dekker;1989.1;p.195-246.

References


175. Chaudhari P, Kolhe S, More D. Formulation development studies of

rizatriptan benzoate fast disintegrating tablet. Res J Pharma, Bio Chem Sci.

2011;2(1):482-96.

176. Charoo NA, Shamsher AAA, Zidan AS, Rahman Z. Quality by design

approach for formulation development: A case study of dispersible tablets. Int

J Pharm. 2012;423:167-78.

177. Singh B, Singh R, Bandyopadhyay S, Kapil R, Garg B. Optimized

nanoemulsifying systems with enhanced bioavailability of carvedilol. Colloids

Surf., B 2013;101:465-474.

178. Mehta S, Beer TD, Remon JP, Vervaet C. Effect of disintegrants on the

properties of multiparticulate tablets comprising starch pellets and excipient

granules. Int J Pharm. 2012;422:310-317.

179. Gohel M, Patel M, Amin A, Agrawal R, Dave R, Bariya N. Formulation

design and optimization of mouth dissolve tablets of nimesulide using vacuum

drying technique. AAPS PharmSciTech. 2004;5(3):1-6

Documents

Nkansah P, Antipas A, Lu Y, Varma M, Rotter C, Rago B, El-Kattan …shodhganga.inflibnet.ac.in/bitstream/10603/32498/16/16... · 2018. 7. 2. · References Dept of Pharmaceutics,